Mederi Therapeutics Inc Greenwich, CT - 06830

Mederi Therapeutics Inc is categorized under in Greenwich, CT and active since 2008.

Mederi Therapeutics Inc was established in 2008, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 4234501 by the NAICS.

If you are seeking more information, feel free to contact William Rutan, Chief Executive Officer at the company’s single location by writing to 8 Sound Shore Drive, Greenwich, Connecticut CT 06830 or by phoning (203) 930-9900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Mederi Therapeutics Inc
Contact Person: William Rutan, Chief Executive Officer
Address: 8 Sound Shore Drive, Greenwich, Connecticut 06830
Phone Number: (203) 930-9900
Website Address: mederitherapeutics.com
Annual Revenue (USD): $10.000.000 to $19.9999.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category:
SIC Code: 3841
NAICS Code: 4234501
Share This Business:

Mederi Therapeutics Inc was started in 2008 to provide professional under the SIC code 3841 and NAICS code 4234501. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.

Feel free to contact William Rutan, Chief Executive Officer for inquiries that concern Mederi Therapeutics Inc by calling the company number (203) 930-9900, as your correspondence is most welcome. Additionally, the physical location of the single location of Mederi Therapeutics Inc can be found at the coordinates 41.028712,-73.602632 as well as the street address 8 Sound Shore Drive in Greenwich, Connecticut 06830.

For its online presence, you may visit Mederi Therapeutics Inc’s website at mederitherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.